Waiting lists for organ transplantation may become a relic of the past thanks to this experimental organ repurposing process.

Scientists at the Diabetes Research Institute are testing different versions of a platform for islet transplantation that could eliminate the need for insulin therapy for type 1 diabetes patients. The platform, known as the DRI BioHub, is a bioengineered “mini organ” that mimics the native pancreas and...